Cargando…
Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the primary malignancy in the liver with high rate of death and recurrence. Novel prognostic model would be crucial for early diagnosis and improved clinical decision. The study aims to provide an effective lncRNA-based signature to predict survival time and tumor r...
Autores principales: | Hao, Fengjie, Wang, Nan, Wang, Xiang, Chen, Yongjun, Wang, Junqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351707/ https://www.ncbi.nlm.nih.gov/pubmed/34285143 http://dx.doi.org/10.18632/aging.203322 |
Ejemplares similares
-
Pseudogene SNRPFP1 derived long non-coding RNA facilitates hepatocellular carcinoma progress in vitro by sponging tumor-suppressive miR-126-5p
por: Wang, Nan, et al.
Publicado: (2022) -
The Controversial Role of Polyploidy in Hepatocellular Carcinoma
por: Wang, Nan, et al.
Publicado: (2021) -
E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcription
por: Hao, Fengjie, et al.
Publicado: (2022) -
Raising of Anillin expression in para-cancerous hepatocytes is associated with hepatic depolyploidization and short-term recurrence of hepatocellular carcinoma after radical operation
por: Wang, Nan, et al.
Publicado: (2022) -
Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2022)